Niacinamide 2% / Spironolactone 5% / Tretinoin 0.025%
Product Images NDC 72934-1152

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Niacinamide 2% / Spironolactone 5% / Tretinoin 0.025% (NDC 72934-1152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dwsd (1152 2 Middle)

Label of NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.025% topical gel. The label lists active ingredients with their strengths and inactive ingredients used in the formulation. It also includes prescription and batch information, along with manufacturer details for Sincerus Florida, LLC.*

FDA Label Image

Ww (1152 2 End)

Text panel showing directions for use of the product NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.025%, including application instructions, storage conditions, manufacturer contact details for reporting adverse reactions, and a note that the product is for office use only and not for resale.*

FDA Label Image

Ww (1152 2 Front)

The image shows a white cylindrical container labeled as NIACINAMIDE USP 2%, SPIRONOLACTONE USP 5%, TRETINOIN USP 0.025% gel, 30 grams. The label includes the NDC 72934-1152-2 and the Sincerus Florida logo, indicating the product is a compounded drug made in the USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.